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ABSTRACT
The serologic relationship and antigenic dominance among five Aujeszky’s disease virus (ADV) isolates, 
designated VBA1, VBA2, VBA3, mA1p and CD, was studied using homologous and heterologous antigens and 
sera. Cross-serum neutralization test (C-SNT) was used to measure antibody responses to the virus. Generally, close 
serologic relationships among ADV isolates were noted. Non-significant (P<0.05) variations in the relationship 
between any two viruses were observed. However, the highest bilateral relationship was observed between 
VBA2 and VBA3 and between VBA2 and CD isolates of the virus. The antigenic dominance of some viruses 
over the others was detected with non-significant (P<0.01) levels, although the higher antigenic dominance was 
observed for CD over VBA3 and mA1p over VBA3 also. In conclusion, neither major serological variations 
nor antigenic dominance among the five ADVs studied were detected in the present study, hence grouped as 
one serologic type. 
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Introduction
Aujeszky’s disease virus (ADV), also known as pseudorabies virus (PrV), is an 
alphaherpesvirus responsible for neuropathological disease in swine (AUJESZKY, 1902) 
and many other domestic and wild animals (PENSAERT and KLUGE, 1989). The serological 
responses to various ADV strains and vaccines were previously examined in laboratory 
animals (WITTMAN et al., 1983; ALI et al., 1998; ALI, 1999; ALI and MOHD-AZMI, 2002) and 
natural host (ALI, 1999). 
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Based on a cross-neutralization test, a minor antigenic relationship has been 
demonstrated between some ADV isolates and other herpesviruses, such as herpes-simplex 
virus (HSV) (TONEVA, 1971) and herpes B virus (WATSON et al., 1967), whereas a close 
antigenic relationship was detected between ADV and bovine herpesvirus-1 (BHV-1) 
(AGUILAR-SETIEN et al., 1979). The serological relationship between some field isolates 
of ADV and conventionally attenuated vaccines have also been studied, claiming they 
were antigenically dominant to the vaccines (KIT, 1989; WARDELY and POST, 1989). The 
present study was designed to determine the serologic relationship and antigenic dominance 
among five ADV isolates from different geographical origins. 
Materials and methods
Viruses. Three isolates of ADV termed VBA1, VBA2 and VBA3 (isolated from 
three different geographical locations in Malaysia during an outbreak in 1994), a 
plaque purified clone of ADV, termed mA1p, and an ADV strain of American origin 
termed CD, were used in this study. The first three isolates and the clone virus 
were kindly supplied by Dr. Mohd-Azmi of Putra University, Malaysia, whereas 
the American ADV strain was kindly provided by Professor Anthony Castro of the 
University of California, Davis (U.S.A.)
Virus propagation and purification. The viruses were propagated in Vero cell 
cultures grown in Leibovitiz-15 (L-15) tissue culture medium supplemented with 5% 
foetal calf serum (FCS), 1% antibiotic-antimycotic and 1% anti-PPLO agents. They 
were purified from Vero cell cultures using the sucrose gradient ultracentrifugation 
method as described by BEN-PORAT et al. (1974), with some modifications.
Preparation of hyperimmune sera (HIS) in mice. Hyperimmune sera against all 
ADV isolates were raised in four-week-old, female BALB/c mice, as described by 
AZMI and FIELD (1993) and ALI (1999). Ten mice (in separate groups) were used for 
each virus. Prior to inoculation of the mice, blood was collected from each of them 
and serum was separated for use as a negative control (pre-immune sera). Purified, 
heat-inactivated virus suspension in L-15 medium containing approximately 107 
p.f.u. per ml (the virus was inactivated by incubation of the virus suspension at 
56 0C for 30 minutes) was emulsified with an equal volume of Freund’s complete 
adjuvant (Gibco BRL, U.S.A.) by means of homogenization until a good emulsion 
was formed. One hundred ml of this emulsion was injected subcutaneously into each 
mouse. At each two-week interval, for six successive weeks, mice were re-injected 
once with the same dose of antigens emulsified in Freund’s incomplete adjuvant 
(Gibco BRL, U.S.A.) The mice were bled weekly to check antibody levels by 
means of ELISA. For the final booster, all mice were injected with live virus only 
(without the adjuvant). Two weeks after the final injection all mice were killed and 
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blood was collected by cardiac puncture. The blood was allowed to clot at room 
temperature for 2-3 hrs and spun at 300 rpm for 5 min. The serum for each group 
was pooled, titrated and stored at -20 °C until use. 
Serum neutralization test (SNT). Twenty-four-well tissue culture plates containing 
confluent monolayer of Vero cells were prepared. The sera to be tested were first 
inactivated at 56 °C for 30 minutes. Two-fold serial dilutions of sera were carried out in 
L-15 medium (supplemented with 2% heat-inactivated FCS and containing 1% of antibiotic-
antimycotic solution and anti-PPLO agent). Aliquots of the serum were mixed with an 
equal volume of live ADV suspension (100 ml containing 100 p.f.u.). Pre-immune sera 
were included in the test as control. For virus neutralization, the mixtures were incubated at 
37 °C for 45 minutes, with continuous shaking using an orbital shaker incubator. One 
hundred-ml aliquots of each mixture were added to the 24-well plates containing the 
confluent Vero cell monolayers in quadruplicate. Four wells of one column were 
inoculated with the virus only (positive control); another 4 wells were inoculated 
with the virus mixed with the control serum (negative control). The virus was 
allowed to adsorb by incubating the plate at 37 °C in 5% CO2 for 45 minutes. Five 
hundred ml of L-15 medium containing 1.2% CMC and 2% FCS were then added.
 The plates were incubated for 2-3 days until plaques developed. The plates were fixed 
with methanol, stained with crystal violet solution and the number of plaques for each 
dilution was determined. The neutralizing antibody titre was determined by plotting serum 
dilution against the number of plaques, and the dilution of the serum (log2) required for 
50% reduction of plaques of the control wells was calculated from the graph according 
to BISCH (1978).
Determination of serologic relationship and antigenic dominance among ADVs 
The bilateral serologic relationship (R) and antigenic dominance (D) between ADV 
isolates were determined according to the method described by PRECAUSTA and 
STELLMANN (1973). The relationship of A to B isolate of the virus was estimated 
according to the following formulae:
r1= 
B virus against A HIS (heterologous) titre
       A virus against A HIS (homologous) titre
r2 = 
A virus against B HIS (heterologous) titre
        B virus against B HIS (homologous) titre
R = 100 × √r1×r2 
              
r1
 
D  = √  —  when D values >1 indicative for dominance.
             r2
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Statistics. The statistical significance of differences between groups of data was 
determined using the two-tailed Student’s unpaired t-test.
Results
The neutralizing Ab titers of all virus isolates obtained against homologous and 
heterologous ADV antigens are shown in Table 1. Each ADV isolate was neutralized by 
homologous as well as heterologous HIS. The homologous neutralizing Ab titers were 
higher for VBA2 and mA1p isolates than heterologous titers, and lower for other viruses. 
PrVs. Hyperimmune sera of VBA1 and VBA3 isolates gave slightly higher (P<0.05) titers 
with VBA2 antigen than with their homologous antigens. Hyperimmune serum of CD isolate 
showed higher potential to neutralize mA1p antigens than to its antigens. For all HIS’s, the 
highest Ab titers were observed when measured against VBA2 and mA1p viruses.




VBA1 VBA2 VBA3 mA1p CD
VBA1  6.8* 6.8 6.9 6.0 6.5
VBA2 6.9 7.0 7.1 6.7 6.5
VBA3 5.6 6.5 6.5 6.3 5.6
mA1p 6.8 6.9 7.0 7.1 6.8
CD 6.5 6.8 7.0 6.5 6.3
* Serum dilution needed to cause 50% reduction in plaque formation (log2)
ADV = Aujeszky’s disease virus, HIS = hyperimmune serum
The serologic relatedness (R) and antigenic dominance (D) among ADVs, estimated 
from their neutralizing Ab titers, are shown in Table 2. The results obtained revealed 
great relationships among the viruses. However, the highest relationship was observed 
between VBA2 and VBA3 and between VBA2 and CD viruses. Dominance evaluation 
showed that VBA2 isolate was dominant over VBA1, mA1p over VBA1, VBA2 and 
VBA3, while CD over VBA3 only. No antigenic dominance for VBA1 and VBA3 over 
any virus is observed.
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Table 2. Bilateral serologic relationship between ADVs and antigenic dominance among them 
estimated from their HIS’s neutralizing antibody titers
ADV antigen
ADV HIS


























* Bilateral relationship; ** Dominance (D value >1 indicative of dominance); ADV = Aujeszky’s 
disease virus, HIS = hyperimmune serum
Discussion 
The present study was designed to determine the serologic relationships and antigenic 
dominance among five ADV isolates and strains originating from different geographical 
sites. The results obtained showed intimate serologic and antigenic relationships among 
the viruses, leading to the fact that they belong to the same serologic subtype. This close 
relationship is proven despite the variations in the number and types of the proteins among 
these viruses responsible for the induction of Ab responses, which we demonstrated in 
previous reports using Western blotting technique (ALI and MOHD-AZMI, 2002; ALI et al., 
2003). This confirms the role of the common proteins, detected in all viruses, in stimulating 
Abs of neutralizing activities. The discrepancy in the findings of SNT and Western blotting 
was previously observed by TODD et al. (1987) and attributed to some inherent characteristic 
of each of these techniques. The same authors emphasized that when employing Western 
blotting, some SDS-solubilized proteins may undergo denaturation after electrophoretic 
transfer, then some polypeptide sequences may show non-specific reactions. 
It is interesting to note that HISs of some viruses (VBA1 and VBA3) showed higher 
neutralizing activity to other viruses (VBA2) than to the homologous antigens. This could 
only be attributed to some errors in the cell culture system used but no data learned can 
support this finding. VBA2 and mA1p viruses displayed the highest neutralizing activity 
against sera of all viruses. This explained their antigenic dominance over the other viruses 
observed later in this study. 
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The great serologic relationships and low antigenic dominance among the viruses 
detected in the present study substantiate their grouping as one serotype to agree with 
PENSAERT and KLUGE (1989), who documented that ADV consist of one serotype. mA1p 
clone virus of ADV was previously confirmed to have high immunogencity and protective 
potential against virulent viruses challenge and hence selected as a good and safe vaccine 
candidate against AD (ALI, 1999). In the present study, this virus also showed antigenic 
dominance over the three Malaysian viruses, which again promote the virus to be a good 
vaccine candidate against AD. 
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SAŽETAK
Upotrebom homolognih i heterolognih antigena i seruma istraživan je serološki odnos i antigenska prevlast 
između pet izolata virusa bolesti Aujeszkoga (VBA) označenih VBA1, VBA2, VBA3, mA1p i CD. Unakrižnim 
serum-neutralizacijskim testom mjerena je količina specifičnih protutijela. Općenito je zapažena jaka serološka 
srodnost između pretraženih izolata. Uočena su beznačajna odstupanja (P<0,05) u srodnosti bilo koja dva izolata. 
Međutim, najjača srodnost uočena je između VBA2 i VBA3 te između VBA2 i CD izolata. Ustanovljeno je da 
antigenska prevlast jednih izolata nad drugima nije bila značajna (P<0,01), iako je uočena nešto veća antigenska 
prevlast CD izolata nad VBA3 te mA1p nad VBA3. Može se zaključiti da u ovom radu nije zabilježeno ni 
značajnije serološko odstupanje niti antigenska prevlast između pet istraživanih izolata virusa bolesti Aujeszkoga 
pa su svrstani u jedan serološki tip. 
Ključne riječi: virus bolesti Aujeszkoga, antigen, protutijela, unakrižna neutralizacija

